• Please log in or register to access this feature.

Article

You have full text access to this OnlineOpen article

Glucose turnover, gluconeogenesis from glycerol, and estimation of net glucose cycling in cancer patients

  1. K. Lundholm MD, PhD*,
  2. S. Edström MD,
  3. I. Karlberg MD,
  4. L. Ekman MD,
  5. T. Scherstén MD, PhD

Article first published online: 28 JUN 2006

DOI: 10.1002/1097-0142(19820915)50:6<1142::AID-CNCR2820500618>3.0.CO;2-I

Issue

Cancer

Cancer

Volume 50, Issue 6, pages 1142–1150, 15 September 1982

Additional Information

How to Cite

Lundholm, K., Edström, S., Karlberg, I., Ekman, L. and Scherstén, T. (1982), Glucose turnover, gluconeogenesis from glycerol, and estimation of net glucose cycling in cancer patients. Cancer, 50: 1142–1150. doi: 10.1002/1097-0142(19820915)50:6<1142::AID-CNCR2820500618>3.0.CO;2-I

Author Information

  1. Surgical Metabolic Research Laboratory, Department of Surgery I and Department of Oto-Rhino-Laryngology, Sahlgrenska Sjukhuset, University of Göteborg, Göteborg, Sweden

*Department of Surgery I, Sahlgrenska sjukhuset, University of Göteborg, S-413 45 Göteborg, Sweden

Publication History

  1. Issue published online: 28 JUN 2006
  2. Article first published online: 28 JUN 2006
  3. Manuscript Accepted: 13 JUL 1981

Funded by

  • Swedish Cancer Society. Grant Number: 93
  • Swedish Medical Research Council. Grant Number: 536
  • Assar Gabrielsson Foundation
  • Swedish Society of Medical Sciences
  • Serena Ehrenström Foundation

SEARCH

SEARCH BY CITATION

ARTICLE TOOLS

Get PDF (812K)

References

  • 1
    Fenninger LD, Mider GB. Energy and nitrogen metabolism in cancer. Adv Cancer Res 1954; 2: 229–252.
  • 2
    Morrison SD. Theoretical review. Control of food intake in cancer cachexia: A challenge and a tool. Physiol Behav 1976; 17: 705–714.
  • 3
    Theologides A. Anorexia-producing intermediary metabolites. Am J Clin Nutr 1976; 29: 552–558.
  • 4
    Waterhouse C. How tumors affect host metabolism. Ann NY Acad Sci 1974; 230: 86–93.
    Direct Link:
  • 5
    Young VR. Energy metabolism and requirements in the cancer patients. Cancer Res 1977; 37: 2336–2347.
  • 6
    Warnold I, Lundholm K, Scherstén T. Energy balance and body composition in cancer patients. Cancer Res 1978; 38: 1801–1807.
  • 7
    Bygrave FL. Mitochondrial calcium transport and the regulation of metabolism by calcium in tumor cells. In: CrissWE, OnoT, SabineJR (eds). Control Mechanisms in Cancer. New York: Raven Press, 1976; 411–423.
  • 8
    Criss WE, Pradhan TK. Regulation of tumor cell metabolism by the adenylate and guanylate energy charges. In: CrissWE, OnoT, SabineJR (eds). Control Mechanisms in Cancer. New York: Raven Press, 1976; 401–410.
  • 9
    Gold J. Cancer cachexia and gluconeogenesis. Ann NY Acad Sci 1974; 230: 103–110.
    Direct Link:
  • 10
    Stein TP. Cachexia, gluconeogenesis and progressive weight loss in cancer patients. J Theor Biol 1978; 73: 51–59.
  • 11
    Holroyde CP, Axelrod RS, Skutches CL, Faff AC, Paul P, Reichard GA. Lactate metabolism in patients with metastatic colorectal cancer. Cancer Res 1979; 39: 4900–4904.
  • 12
    Holroyde CP, Gaduzda TG, Putnam RC, Paul P, Reichard GA. Altered glucose metabolism in metastatic carcinoma. Cancer Res 1975; 35: 3710–3714.
  • 13
    Reichard GA Jr, Moury NF Jr, Hochella NJ, Patterson AL, Weinhouse S. Qualitative estimation of the Cori cycle in the human. J Biol Chem 1963; 238: 495–501.
  • 14
    Waterhouse C. Lactate metabolism in patients with cancer. Cancer 1974; 33: 66–71.
    Direct Link:
  • 15
    Waterhouse C, Jeanpretre N, Keilson J. Gluconeogenesis from alanine in patients with progressive malignant disease. Cancer Res 1979; 39: 1968–1972.
  • 16
    Gershanovich ML, Filov VA. Hydrazine sulfate in late stage cancer: Completion of initial clinical trials in 225 evaluable patients. Proceedings, Fifteenth Annual Meeting of the American Society of Clinical Oncology 1979; 20: 240.
  • 17
    Katz J, Rostami H, Dunn A. Evaluation of glucose turnover, body mass and recycling with reversible and irreversible tracers. Biochem J 1974; 142: 161–170.
  • 18
    Katz J, Dunn A, Chenoweth M, Golden S. Determination of synthesis, recycling and body mass of glucose in rats and rabbits in vivo with 3H- and 14C-labelled glucose. Biochem J 1974; 142: 171–183.
  • 19
    Reichard GA Jr, Moury NF Jr, Hochella NJ, Putnam RC, Weinhouse S. Metabolism of neoplastic tissue. XVII: Blood glucose replacement rates in human cancer patients. Cancer Res 1964; 24: 71–76.
  • 20
    Reichard GA Jr, Jacobs AG, Friedmann B, Kimdel PR, Hochella NJ, and Weinhouse S. Effects of insulin and tolbutamide on production and utilization of blood sugar. Metabolism 1959; 8: 486–492.
  • 21
    Blomqvist N, Lindstedt G, Lundberg P-A, Wålinder J. No inhibition by Li+ of thyroxine monodeiodination to 3,5,3′-triiodothyronine and 3,3′,5′-triiodothyronine (reverse triiodothyronine). Clin Chim Acta 1977; 79: 457–464.
  • 22
    Nilsson S, Scherstén T. Synthesis of phospholipids and triglycerides in human liver slices. I: Experimental conditions and the synthesis rate in normal liver tissue. Scand J Clin Lab Invest 1969; 24: 237–249.
  • 23
    Okajima F, Uj M. Metabolism of glucose in hyper- and hypothyroid rats in vivo: Glucose-turnover values and futile-cycle activities obtained with 14C- and 3H-labelled glucose. Biochem J 1979; 182: 565–575.
  • 24
    Siegel S. The Spearman rank correlation coefficient. In: HarlowHF, ed. Nonparametric Statistics for the Behavioral Sciences, International Student Ed. New York: McGraw-Hill, 1956; 202–231.
  • 25
    Gavin L, Castle J, McMahon F, Martin P, Hammond M, Cavalieri RR. Extrathyroidal conversion of thyroxine to 3,3′,5′-triiodothyronine (reverse-T3) and 3,5,3′-triiodothyronine (reverse-T3) in humans. J Clin Endocrinol Metab 1977; 44: 733–742.
  • 26
    Singh J, Gregor M, Thompsson MP. Glucose homeostasis in rats bearing a transplantable sarcoma. Cancer Res 1980; 40: 1699–1706.
  • 27
    Lundholm K, Edström S, Karlberg I, Ekman L, Scherstén T. Relationship of food intake, body composition and tumor growth to host metabolism in nongrowing mice with sarcoma. Cancer Res 1980; 40: 2516–2522.
  • 28
    Nikkilä EA, Ojala K. Gluconeogenesis from glycerol in fasting rats. Life Sci 1964; 3: 243–249.
  • 29
    Malmendier CL, Delcroix C, Berman M. Interrelations in the oxidative metabolism of free fatty acids, glucose, and glycerol in normal and hyperlipemic patients: A comparative model. J Clin Invest 1974; 54: 461–476.
  • 30
    Okajima F, Ui M. Metabolism of glucose in hyper-and hyperthyroid rats in vivo: Relation of catecholamine actions to thyroid activity in controlling glucose-turnover. Biochem J 1979; 182: 585–592.
  • 31
    Okajima F, Ui M. Metabolism of glucose in hyper- and hypothyroid rats in vivo: Minor role of endogenous insulin in thyroid-dependent changes in glucose-turnover. Biochem J 1979; 182: 577–584.
  • 32
    Goodlad GAJ, Clark CM. Leucine metabolism in skeletal muscle of the tumour-bearing rat. Eur J Cancer 1980; 16: 1153–1162.
  • 33
    Lundholm K, Bylund A-C, Scherstén T. Glucose tolerance in relation to skeletal muscle enzyme activities in cancer patients. Scand J Clin Lab Invest 1977; 37: 267–272.
  • 34
    Lundholm K, Bylund A-C, Holm J, Scherstén T. Skeletal muscle metabolism in patients with malignant tumor. Eur J Cancer 1976; 12: 465–473.
  • 35
    Lundholm K, Holm G, Scherstén T. Insulin resistance in patients with cancer. Cancer Res 1978; 38: 4665–4670.
  • 36
    Chang TW, Goldberg AL. The origin of alanine produced in skeletal muscle. J Biol Chem 1978; 253: 3677–3684.
  • 37
    Garber AJ, Karl IE, Kipnis DM. Alanine and glutamine synthesis and release from skeletal muscle. I: Glycolysis and amino acid release. J Biol Chem 1976; 251: 826–835.
  • 38
    Felig PH, Wahren J. Protein turnover and amino acid metabolism in the regulation of gluconeogenesis. Fed Proc 1974; 33: 1092–1097.
  • 39
    Shapot VS. On the multiform relationships between the tumor and the host. Adv Cancer Res 1979; 30: 89–150.
  • 40
    Monakhov NK, Neistadt EL, Shavlovskii MM, Shvartsman AL, Neifakh SA. Physico-chemical properties and isoenzyme composition of hexokinase from normal and malignant human tissues. J Natl Cancer Inst 1978; 61: 27–33.
Get PDF (812K)